Carisma Therapeutics, Inc. ( CARM) - Stock Earnings
CARM Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 5, 2026, midnight | — / — | — | — / — | — |
CARM Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q1 | -9.3 million USD | 3.7 million USD |
| 2025Q2 | -9.8 million USD | — USD |
| 2025Q3 | 44.7 million USD | 45.3 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
CARM Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2022 | -61.2 million USD | 9.8 million USD |
| 2023 | -86.9 million USD | 14.9 million USD |
| 2024 | -60.5 million USD | 19.6 million USD |
| 2026 Est. | — | — |
CARM
Price: $0
52 week price:
Earnings Per Share: 0.19 USD
P/E Ratio: 0.00
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 20923